Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial
A. K. Stewart, R. Vescio, G. Schiller, O. Ballester, S. Noga, H. Rugo, C. Freytes, E. Stadtmauer, S. Tarantolo, F. Sahebi, P. Stiff, J. Meharchard, R. Schlossman, R. Brown, H. Tully, M. Benyunes, C. Jacobs, R. Berenson, M. White, J. DipersioK. C. Anderson, J. Berenson
Resultado de la investigación: Article › revisión exhaustiva
Profundice en los temas de investigación de 'Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: Results of a multicenter randomized controlled trial'. En conjunto forman una huella única.